Recent News

• 03.03.2025 - Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
• 03.03.2025 - Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
• 02.28.2025 - Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule
• 02.28.2025 - Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule

Recent Filings

• 03.03.2025 - EX-99.1 EX-99.1
• 03.03.2025 - 8-K Current report
• 02.28.2025 - EX-99.1 EX-99.1
• 02.28.2025 - 8-K Current report
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 8-K Current report
• 02.18.2025 - 8-K Current report
• 02.18.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors